-
公开(公告)号:US06448269B1
公开(公告)日:2002-09-10
申请号:US09883639
申请日:2001-06-18
申请人: Matthew J. Fisher , Anne Marie Happ , Joseph A. Jakubowski , Michael Dean Kinnick , Allen D. Kline , Michael John Martinelli , John Michael Morin, Jr. , Michael Paal , Gerd Rühter , Kenneth James Ruterbories , Daniel J. Sall , Theo Schotten , Marshall A. Skelton , Wolfgang Stenzel , Robert Theodore Vasileff
发明人: Matthew J. Fisher , Anne Marie Happ , Joseph A. Jakubowski , Michael Dean Kinnick , Allen D. Kline , Michael John Martinelli , John Michael Morin, Jr. , Michael Paal , Gerd Rühter , Kenneth James Ruterbories , Daniel J. Sall , Theo Schotten , Marshall A. Skelton , Wolfgang Stenzel , Robert Theodore Vasileff
IPC分类号: C07D40112
CPC分类号: C07D311/22 , C07C257/18 , C07C271/64 , C07C2602/10 , C07D211/22 , C07D211/34 , C07D213/82 , C07D217/04 , C07D217/06 , C07D217/24 , C07D311/58 , C07D333/38 , C07D401/12 , C07D405/06 , C07D405/12
摘要: This invention relates to certain bicyclic compounds having a nucleus formed of two fused six membered rings, for example, benzopyran, isoquinoline, isoquinolone, tetrahydronaphthalene, dihydronaphthalene, or tetralone, substituted with both basic and acidic functionality, which are useful in inhibition of platelet aggregation.
摘要翻译: 本发明涉及具有由两个稠合的六元环形成的核的某些二环化合物,例如苯并吡喃,异喹啉,异喹诺酮,四氢萘,二氢萘或四氢萘酮,其被碱性和酸性官能团所取代,其可用于抑制血小板聚集 。
-
公开(公告)号:US6020362A
公开(公告)日:2000-02-01
申请号:US47285
申请日:1998-03-24
申请人: Matthew J. Fisher , Anne Marie Happ , Joseph A. Jakubowski , Michael Dean Kinnick , Allen D. Kline , Michael John Martinelli , John Michael Morin, Jr. , Michael Paal , Gerd Ruhter , Kenneth James Ruterbories , Daniel J. Sall , Theo Schotten , Marshall A. Skelton , Wolfgang Stenzel , Robert Theodore Vasileff
发明人: Matthew J. Fisher , Anne Marie Happ , Joseph A. Jakubowski , Michael Dean Kinnick , Allen D. Kline , Michael John Martinelli , John Michael Morin, Jr. , Michael Paal , Gerd Ruhter , Kenneth James Ruterbories , Daniel J. Sall , Theo Schotten , Marshall A. Skelton , Wolfgang Stenzel , Robert Theodore Vasileff
IPC分类号: C07D487/04 , A61K31/195 , A61K31/215 , A61K31/335 , A61K31/35 , A61K31/352 , A61K31/38 , A61K31/381 , A61K31/44 , A61K31/4427 , A61K31/443 , A61K31/445 , A61K31/4465 , A61K31/47 , A61K31/472 , A61K31/495 , A61P7/02 , A61P9/10 , C07C257/18 , C07C257/20 , C07C271/64 , C07D211/22 , C07D211/32 , C07D211/34 , C07D213/82 , C07D217/04 , C07D217/06 , C07D217/24 , C07D221/00 , C07D311/22 , C07D311/58 , C07D311/66 , C07D311/70 , C07D319/16 , C07D333/38 , C07D401/12 , C07D405/06 , C07D405/12 , C07D491/052 , C07D497/04 , G03F7/20 , C07D311/04
CPC分类号: C07D211/34 , C07C257/18 , C07C271/64 , C07D211/22 , C07D213/82 , C07D217/04 , C07D217/06 , C07D217/24 , C07D311/22 , C07D311/58 , C07D333/38 , C07D401/12 , C07D405/06 , C07D405/12 , C07C2102/10
摘要: This invention relates to certain bicyclic compounds having a nucleus formed of two fused six membered rings, for example, benzopyran, isoquinoline, isoquinolone, tetrahydronaphthalene, dihydronaphthalene, or tetralone, substituted with both basic and acidic functionality, which are useful in inhibition of platelet aggregation.
摘要翻译: 本发明涉及具有由两个稠合的六元环形成的核的某些二环化合物,例如苯并吡喃,异喹啉,异喹诺酮,四氢萘,二氢萘或四氢萘酮,其被碱性和酸性官能团所取代,其可用于抑制血小板聚集 。
-
公开(公告)号:US5731324A
公开(公告)日:1998-03-24
申请号:US376191
申请日:1995-01-19
申请人: Matthew J. Fisher , Anne Marie Happ , Joseph A. Jakubowski , Michael Dean Kinnick , Allen D. Kline , Michael John Martinelli , John Michael Morin, Jr. , Michael Paal , Gerd Ruhter , Kenneth James Ruterbories , Daniel J. Sall , Theo Schotten , Marshall A. Skelton , Wolfgang Stenzel , Robert Theodore Vasileff
发明人: Matthew J. Fisher , Anne Marie Happ , Joseph A. Jakubowski , Michael Dean Kinnick , Allen D. Kline , Michael John Martinelli , John Michael Morin, Jr. , Michael Paal , Gerd Ruhter , Kenneth James Ruterbories , Daniel J. Sall , Theo Schotten , Marshall A. Skelton , Wolfgang Stenzel , Robert Theodore Vasileff
IPC分类号: C07D487/04 , A61K31/195 , A61K31/215 , A61K31/335 , A61K31/35 , A61K31/352 , A61K31/38 , A61K31/381 , A61K31/44 , A61K31/4427 , A61K31/443 , A61K31/445 , A61K31/4465 , A61K31/47 , A61K31/472 , A61K31/495 , A61P7/02 , A61P9/10 , C07C257/18 , C07C257/20 , C07C271/64 , C07D211/22 , C07D211/32 , C07D211/34 , C07D213/82 , C07D217/04 , C07D217/06 , C07D217/24 , C07D221/00 , C07D311/22 , C07D311/58 , C07D311/66 , C07D311/70 , C07D319/16 , C07D333/38 , C07D401/12 , C07D405/06 , C07D405/12 , C07D491/052 , C07D497/04 , G03F7/20 , C07D311/02
CPC分类号: C07D211/34 , C07C257/18 , C07C271/64 , C07D211/22 , C07D213/82 , C07D217/04 , C07D217/06 , C07D217/24 , C07D311/22 , C07D311/58 , C07D333/38 , C07D401/12 , C07D405/06 , C07D405/12 , C07C2102/10
摘要: This invention relates to certain bicyclic compounds having a nucleus formed of two fused six membered rings, for example, benzopyran, isoquinoline, isoquinolone, tetrahydronaphthalene, dihydronaphthalene, or tetralone, substituted with both basic and acidic functionality, which are useful in inhibition of platelet aggregation.
-
公开(公告)号:US6137002A
公开(公告)日:2000-10-24
申请号:US710823
申请日:1996-09-23
申请人: Matthew J. Fisher , Anne Marie Happ , Joseph A. Jakubowski , Michael Dean Kinnick , Allen D. Kline , John Michael Morin, Jr. , Daniel J. Sall , Marshall A. Skelton , Robert Theodore Vasileff
发明人: Matthew J. Fisher , Anne Marie Happ , Joseph A. Jakubowski , Michael Dean Kinnick , Allen D. Kline , John Michael Morin, Jr. , Daniel J. Sall , Marshall A. Skelton , Robert Theodore Vasileff
IPC分类号: C07D487/04 , A61K31/195 , A61K31/215 , A61K31/335 , A61K31/35 , A61K31/352 , A61K31/38 , A61K31/44 , A61K31/47 , A61K31/472 , A61K31/495 , A61P7/02 , A61P9/10 , C07C257/18 , C07C271/64 , C07D211/22 , C07D211/34 , C07D213/82 , C07D217/04 , C07D217/06 , C07D217/24 , C07D221/00 , C07D311/22 , C07D311/58 , C07D333/38 , C07D401/12 , C07D405/06 , C07D405/12 , C07D491/052 , C07D497/04 , G03F7/20 , C07C251/02
CPC分类号: C07C257/18 , C07C271/64 , C07D211/22 , C07D211/34 , C07D213/82 , C07D217/04 , C07D217/06 , C07D217/24 , C07D311/22 , C07D311/58 , C07D333/38 , C07D401/12 , C07D405/06 , C07D405/12 , C07C2102/10
摘要: This invention relates to certain bicyclic compounds having a nucleus formed of two fused six membered rings, for example, isoquinoline, isoquinolone, tetrahydronaphthalene, dihydronaphthalene, or tetralone, substituted with both basic and acidic functionality, which are useful in inhibition of platelet aggregation.
-
公开(公告)号:US06472405B1
公开(公告)日:2002-10-29
申请号:US09299404
申请日:1999-04-26
申请人: Matthew J. Fisher , Anne Marie Happ , Joseph A. Jakubowski , Michael Dean Kinnick , Allen D. Kline , John Michael Morin, Jr. , Daniel J. Sall , Marshall A. Skelton , Robert Theodore Vasileff
发明人: Matthew J. Fisher , Anne Marie Happ , Joseph A. Jakubowski , Michael Dean Kinnick , Allen D. Kline , John Michael Morin, Jr. , Daniel J. Sall , Marshall A. Skelton , Robert Theodore Vasileff
IPC分类号: C07D21716
CPC分类号: C07C257/18 , C07C271/64 , C07C2602/10 , C07D211/22 , C07D211/34 , C07D213/82 , C07D217/04 , C07D217/06 , C07D217/24 , C07D311/22 , C07D311/58 , C07D333/38 , C07D401/12 , C07D405/06 , C07D405/12
摘要: This invention relates to certain bicyclic compounds having a nucleus formed of two fused six membered rings, for example, isoquinoline, isoquinolone, tetrahydronaphthalene, dihydronaphthalene, or tetralone, substituted with both basic and acidic functionality, which are useful in inhibition of platelet aggregation.
摘要翻译: 本发明涉及具有由两个稠合的六元环形成的核的二环化合物,例如异喹啉,异喹啉酮,四氢萘,二氢萘或四氢萘酮,其被碱性和酸性官能团所取代,其可用于抑制血小板聚集。
-
公开(公告)号:US06013674A
公开(公告)日:2000-01-11
申请号:US71684
申请日:1998-05-01
申请人: John Michael Morin, Jr. , Michael Dean Kinnick , Robert Theodore Vasileff , William Thomas Jackson
发明人: John Michael Morin, Jr. , Michael Dean Kinnick , Robert Theodore Vasileff , William Thomas Jackson
IPC分类号: A61K31/165 , A61K31/166 , A61P11/00 , A61P25/28 , A61P29/00 , A61P43/00 , C07C235/82
CPC分类号: A61K31/166 , C07C235/82 , C07C2102/08 , Y10S514/821 , Y10S514/825 , Y10S514/826 , Y10S514/863 , Y10S514/886 , Y10S514/908 , Y10S514/927
摘要: This invention provides novel indenone derivatives, their pharmaceutical formulations and their use for the inhibition of leukocyte adherence to cells.
摘要翻译: 本发明提供新的茚酮酮衍生物,其药物制剂及其用于抑制白细胞对细胞粘附的用途。
-
公开(公告)号:US06177440B1
公开(公告)日:2001-01-23
申请号:US09063066
申请日:1998-04-21
申请人: Nicholas James Bach , Susan Elizabeth Draheim , Robert Delane Dillard , Edward David Mihelich , Jason Scott Sawyer , Douglas Wade Beight , Michael LeRoy Phillips , Tulio Suarez , Daniel Jon Sall , Jolie Anne Bastian , Michael Lyle Denney , Gary Alan Hite , Michael Dean Kinnick , Robert Theodore Vasileff , John Michael Morin, Jr. , Ho-Shen Lin , Michael Enrico Richett , Richard Waltz Harper , John McNeill McGill, III , Benjamin Alan Anderson , Nancy Kay Harn , Richard James Loncharich , Richard Walter Schevitz
发明人: Nicholas James Bach , Susan Elizabeth Draheim , Robert Delane Dillard , Edward David Mihelich , Jason Scott Sawyer , Douglas Wade Beight , Michael LeRoy Phillips , Tulio Suarez , Daniel Jon Sall , Jolie Anne Bastian , Michael Lyle Denney , Gary Alan Hite , Michael Dean Kinnick , Robert Theodore Vasileff , John Michael Morin, Jr. , Ho-Shen Lin , Michael Enrico Richett , Richard Waltz Harper , John McNeill McGill, III , Benjamin Alan Anderson , Nancy Kay Harn , Richard James Loncharich , Richard Walter Schevitz
IPC分类号: A61K3144
CPC分类号: C07D209/88
摘要: A class of novel tricyclics is disclosed together with the use of such compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock.
摘要翻译: 公开了一类新型三环类药物,以及这些化合物用于抑制sPLA2介导的脂肪酸释放以治疗诸如败血性休克的病症。
-
公开(公告)号:US06713645B1
公开(公告)日:2004-03-30
申请号:US09688106
申请日:2000-10-13
申请人: Nicholas James Bach , Susan Elizabeth Draheim , Robert Delane Dillard , Edward David Mihelich , Jason Scott Sawyer , Douglas Wade Beight , Michael LeRoy Phillips , Tulio Suarez , Daniel Jon Sall , Jolie Anne Bastian , Michael Lyle Denney , Gary Alan Hite , Michael Dean Kinnick , Robert Theodore Vasileff , John Michael Morin, Jr. , Ho-Shen Lin , Michael Enrico Richett , Richard Waltz Harper , John McNeill McGill, III , Benjamin Alan Anderson , Nancy Kay Harn , Richard James Loncharich , Richard Walter Schevitz
发明人: Nicholas James Bach , Susan Elizabeth Draheim , Robert Delane Dillard , Edward David Mihelich , Jason Scott Sawyer , Douglas Wade Beight , Michael LeRoy Phillips , Tulio Suarez , Daniel Jon Sall , Jolie Anne Bastian , Michael Lyle Denney , Gary Alan Hite , Michael Dean Kinnick , Robert Theodore Vasileff , John Michael Morin, Jr. , Ho-Shen Lin , Michael Enrico Richett , Richard Waltz Harper , John McNeill McGill, III , Benjamin Alan Anderson , Nancy Kay Harn , Richard James Loncharich , Richard Walter Schevitz
IPC分类号: C07C6976
CPC分类号: C07D409/04 , C07D209/88 , C07F9/5728
摘要: A class of novel tricyclics is disclosed together with the use of such compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock.
摘要翻译: 公开了一类新型三环类药物,以及这些化合物用于抑制sPLA2介导的脂肪酸释放以治疗诸如败血性休克的病症。
-
9.Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes 失效
标题翻译: 用作黑色素浓缩激素拮抗剂治疗肥胖和糖尿病的多环化合物公开(公告)号:US07229987B2
公开(公告)日:2007-06-12
申请号:US10512986
申请日:2003-05-06
申请人: Jochen Ammenn , James Ronald Gillig , Lawrence Joseph Heinz , Philip Arthur Hipskind , Michael Dean Kinnick , Yen-Shi Lai , John Michael Morin, Jr. , James Arthur Nixon , Carsten Ott , Kenneth Allen Savin , Theo Schotten , Lawrence John Slieker , Nancy June Snyder , Michael Alan Robertson
发明人: Jochen Ammenn , James Ronald Gillig , Lawrence Joseph Heinz , Philip Arthur Hipskind , Michael Dean Kinnick , Yen-Shi Lai , John Michael Morin, Jr. , James Arthur Nixon , Carsten Ott , Kenneth Allen Savin , Theo Schotten , Lawrence John Slieker , Nancy June Snyder , Michael Alan Robertson
IPC分类号: A61K31/5355 , A61K31/454 , C07D401/12 , C07D403/12 , C07D263/32
CPC分类号: C07D249/08 , C07D261/08 , C07D263/32 , C07D271/06 , C07D271/10 , C07D271/107 , C07D277/26 , C07D333/18 , C07D413/04 , C07D413/06 , C07D413/10 , C07D413/12 , C07D413/14 , C07D417/12
摘要: The present invention relates to a melanin concentrating hormone antagonist compound of formula I: (I); or a pharmaceutically acceptable salt, solvate, enantiomer or prodrug thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and related diseases.
摘要翻译: 本发明涉及式I的黑色素浓缩激素拮抗剂化合物:(I); 或其药学上可接受的盐,溶剂化物,对映异构体或前药,用于治疗,预防或改善与肥胖症和相关疾病相关的症状。
-
公开(公告)号:US06992100B2
公开(公告)日:2006-01-31
申请号:US10450745
申请日:2001-12-06
申请人: Douglas Wade Beight , Michael Dean Kinnick , Ho-Shen Lin , John Michael Morin, Jr. , Michael Enrico Richett , Daniel Jon Sall , Jason Scott Sawyer , John David Jandzinski
发明人: Douglas Wade Beight , Michael Dean Kinnick , Ho-Shen Lin , John Michael Morin, Jr. , Michael Enrico Richett , Daniel Jon Sall , Jason Scott Sawyer , John David Jandzinski
IPC分类号: A61K31/403 , C07D209/56
CPC分类号: A61K31/403 , A61K31/407 , A61K31/4745
摘要: A novel class of tetracyclic compounds is disclosed together with the use of such compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of Inflammatory Diseases such as septic shock.
摘要翻译: 公开了一类新的四环化合物以及这些化合物用于抑制sPLA2介导的脂肪酸释放以治疗炎性疾病如脓毒性休克的用途。
-
-
-
-
-
-
-
-
-